Page 1673 - Clinical Small Animal Internal Medicine
P. 1673
Index 1611
HS see histiocytic sarcoma hypereosinophilic syndrome 549 metabolic bone diseases
VetBooks.ir HSCT see hematopoietic stem cell hyperglobulinemia 649–650, 874 metabolic diseases 678
1527–1528
hyperesthesia 818
HSA see hemangiosarcoma; human
serum albumin
hyperglycemia
statistical interpretation for
transplantation critical care setting 350 practitioners 15
HT see systemic hypertension diabetes mellitus 93–94, 96–101 see also feline hyperthyroidism
human–animal bond metabolic diseases 679 hypertonic saline 358–359, 360,
behavioral problems 1572 hyperinflated lungs 298 409, 755
end‐of‐life care 1560–1561, hyperkalemia see potassium hypertrophic cardiomyopathy (HCM)
1563–1564, 1563 homeostasis and disorders canine myocardial disease 265
human anti‐rabies immune globulin hyperkeratosis 1492, 1502 cardiogenic shock 415
(HRIG) 897 hyperkinetic movement cardiovascular disease 123, 136
human‐directed aggression 1574 disorders 768–769, 768, 771 feline myocardial disease
human leukocyte antigen (HLA) 113 hyperlipidemia 593, 599 267–273
human melanoma hypermagnesemia see magnesium heart failure 178, 190
immunotherapy 1351 homeostasis and disorders myelopathy 821
human serum albumin (HSA) 363 hypernatremia see sodium and water hypertrophic osteodystrophy
humidification 399 homeostasis (HOD) 1549–1550
hunger 1559 hyperoxaluria 1126 hypertrophic osteopathy
HVS see hyperviscosity syndrome hyperparathyroidism 1082, (HO) 1220, 1279
hydration and dehydration 1522–1523 hyperventilation 367, 757
acute kidney injury 1092 hyperphosphatemia see phosphorus hyperviscosity syndrome
chronic kidney disease 1170 homeostasis and disorders (HVS) 1241, 1244
end‐of‐life care 1559, 1559 hyperpigmentation/hypermelanosis hypoadrenocorticism
fluid therapy 361–362, 364 approach to the dermatologic (HOAC) 81–92
see also sodium and water patient 1387 atypical hypoadrenocorticism
homeostasis atopic dermatitis 1405 87–88
hydrogen peroxide 442 bacterial pyodermas 1463–1464 autoimmune polyglandular
hydroxyapatite cutaneous adverse food syndromes 113–115
(HA) 1129–1130, 1512 reactions 1420 cats 88–92
hydroxyethyl starches (HES) 359 hyperproteinemia 298 diagnosis 82–85, 88–91
hygiene 1559–1560 hypersensitivity reactions dogs 81–88
hypalgesia 735 allergic skin diseases 1414–1415, epidemiology/signalment
hyperadrenocorticism (HAC) 1415 82, 88, 90
endocrine manifestations of antimicrobials 1045, 1047 etiology/pathophysiology 81,
cancer 1213 feline bronchial asthma 297 88–90
endocrinology 30, 32 venomous snake bites 461, history and clinical signs 82, 88, 90,
hepatobiliary disease 662 462–463 90, 90
pituitary‐dependent hypertension hyperaldosteronism in cats
hyperadrenocorticism 49–63 chronic kidney disease 1165, 1167, 89–92
polyuria and polydipsia 67 1168–1170 hypoglycemia 107
systemic hypertension 220, 223 critical care setting 349 motility disorders 564
urolithiasis 1126–1127 glomerular disease 1105–1106, polyuria and polydipsia 67, 86, 88
see also Cushing disease 1105 prognosis 87, 89, 92
hyperaldosteronism 89–92, 220 head trauma 755, 757 treatment 85–87, 89, 91
hyperbilirubinemia 651, 874 vestibular disease 792–793 hypoalbuminemia
hypercalcemia see calcium homeostasis see also systemic hypertension feline coronavirus 874
and disorders hyperthermia 433–434 hypoadrenocorticism 83
hypercapneic respiratory failure etiology/pathophysiology liver disease 649
381–383, 388–389 433–434 metabolic diseases 682
hypercapnia see hypoventilation head trauma 750 septic shock 425
hypercholesterolemia 651 surgical approaches to thoracic hypoalbuminuria 1102–1103
hypercoagulability 316–317, 317 disease 330 hypocalcemia see calcium homeostasis
hypercorticolism 1481–1482 treatment 434 and disorders
hyperemia 515 hyperthyroidism hypocholesterolemia 83
